We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Raps Hospira for Repeat Violations at Kansas Plant
FDA Raps Hospira for Repeat Violations at Kansas Plant
The FDA slammed Hospira’s sterile drug facility in McPherson, Kansas, after finding the same violations during recent inspections that were flagged during earlier probes.